Harish Shantharam
Chief Financial Officer · ALX ONCOLOGY HOLDINGS INC
- 2025
- Jan 28, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Harish Shantharam files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Corey S. Goodman - $5.00M in ALXO purchases and sales in the last 12 months
- Jason Lettmann - $31K in ALXO purchases and sales in the last 12 months
- Shelly Pinto - $12K in ALXO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Harish Shantharam?
Harish Shantharam is a corporate insider, tracked as Chief Financial Officer of ALX ONCOLOGY HOLDINGS INC (ALXO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Harish Shantharam last file a Form 4?
The most recent primary Form 4 on record is dated 28 January 2026, one of 3 filings going back to 2025.
Has Harish Shantharam been buying or selling stock?
Recorded transactions: 1 open-market purchase ($58K) and 0 open-market sales across all tracked filings.
